Article Details

KKR may invest in Max Group; Carlyle top contender for stake in Mankind Pharma

Retrieved on: 2018-01-22 15:41:15

Tags for this article:

Click the tags to see associated articles and topics

KKR may invest in Max Group; Carlyle top contender for stake in Mankind Pharma. View article details on hiswai:

Excerpt

<div>Private equity giant <b>Kohlberg Kravis Roberts</b> and Co. Ltd (KKR) is set to provide flexible partnership capital of around Rs 2,000 crore ($315 million) to the Analjit Singh-led diversified Max Group, The Economic Times reported citing multiple people aware of the development. The fund infusion will help ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up